Cargando…

New targeted therapies in myelodysplastic syndrome: the role of farnesyltransferase and proteasome inhibitors

Detalles Bibliográficos
Autores principales:	Gonçalves, A Cristina, Oliveira, Ana, Moreira, Diana, Neves, Silvia, Alves, Vera, Silva, Teresa, Mesquita, Luís, Coimbra, Henriqueta, Dourado, Marília, Nascimento-Costa, José M, SarmentoRibeiro, Ana B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255042/

Ejemplares similares

The role of CD26 and CD40 expression in therapeutic response - experimental study in oral cancer lines
por: Batista, Joana PN, et al.
Publicado: (2010)

Histone deacetylation - a new epigenetic target in cancer
por: Carvalho, João A, et al.
Publicado: (2010)

DNA Methylation Is Correlated with Oxidative Stress in Myelodysplastic Syndrome—Relevance as Complementary Prognostic Biomarkers
por: Gonçalves, Ana Cristina, et al.
Publicado: (2021)

Oxidative Stress Parameters Can Predict the Response to Erythropoiesis-Stimulating Agents in Myelodysplastic Syndrome Patients
por: Gonçalves, Ana Cristina, et al.
Publicado: (2021)

Recombinant trail: a synergistic effect in myeloid leukemias
por: Carvalho, Filipa, et al.
Publicado: (2010)

Platelet Membrane Proteins as Pain Biomarkers in Patients with Severe Dementia
por: Ribeiro, Hugo, et al.
Publicado: (2023)

Monocytes in the Characterization of Pain in Palliative Patients with Severe Dementia—A Pilot Study
por: Ribeiro, Hugo, et al.
Publicado: (2023)

Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase
por: Weber, Lea, et al.
Publicado: (2021)

Apoptosis and (in) Pain—Potential Clinical Implications
por: Ribeiro, Hugo, et al.
Publicado: (2022)

Evaluation of the role of mir-34b in modulation of radioresistance in non-small cell lung cancer
por: Silva, Joana B, et al.
Publicado: (2010)

New targets for therapy in breast cancer: Farnesyltransferase inhibitors
por: Head, Julia, et al.
Publicado: (2004)

Engineering Protein Farnesyltransferase for Enzymatic Protein Labeling Applications
por: Dozier, Jonathan K., et al.
Publicado: (2014)

Effect of farnesyltransferase inhibitor on the function of mitochondria of Plasmodium falciparum
por: Ha, Young Ran, et al.
Publicado: (2012)

An overview on natural farnesyltransferase inhibitors for efficient cancer therapy
por: Dai, Xiaohan, et al.
Publicado: (2020)

Effect of farnesyltransferase inhibitors on SARS-CoV-2
por: Weber, Lea, et al.
Publicado: (2023)

Analyzing the postulated inhibitory effect of Manumycin A on farnesyltransferase
por: Hagemann, Anna, et al.
Publicado: (2022)

Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria
por: Yang, Shao H., et al.
Publicado: (2010)

Effect of Farnesyltransferase Inhibitor R115777 on Mitochondria of Plasmodium falciparum
por: Ha, Young Ran, et al.
Publicado: (2015)

Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni
por: Probst, Alexandra, et al.
Publicado: (2019)

Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments
por: Ha, Nguyen Thi, et al.
Publicado: (2020)

Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts
por: Gabriel, Diana, et al.
Publicado: (2017)

Inhibition of oncogene-induced inflammatory chemokines using a farnesyltransferase inhibitor
por: DeGeorge, Katharine C, et al.
Publicado: (2008)

In Vitro Apoptotic Effects of Farnesyltransferase blockade in Acute Myeloid Leukemia Cells
por: Giudice, V, et al.
Publicado: (2016)

A Farnesyltransferase Acts to Inhibit Ectopic Neurite Formation in C. elegans
por: Carr, David, et al.
Publicado: (2016)

MALDI-MS Analysis of Peptide Libraries Expands the Scope of Substrates for Farnesyltransferase
por: Schey, Garrett L., et al.
Publicado: (2021)

Phenothiazine- and Carbazole-Cyanochalcones as Dual Inhibitors of Tubulin Polymerization and Human Farnesyltransferase
por: Zubaș, Andreea, et al.
Publicado: (2023)

Delocalized lipophilic cations as a new therapeutic approach in cancer
por: Ribeiro, A Barbosa, et al.
Publicado: (2010)

In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida
por: Qiao, Jianjun, et al.
Publicado: (2013)

Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells
por: Ma, Yufang, et al.
Publicado: (2017)

Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors
por: Nigam, Aradhya, et al.
Publicado: (2023)

Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
por: Jorge, Joana, et al.
Publicado: (2023)

Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)
por: Gajewski, Thomas F, et al.
Publicado: (2012)

Preventing farnesylation of the dynein adaptor Spindly contributes to the mitotic defects caused by farnesyltransferase inhibitors
por: Holland, Andrew J., et al.
Publicado: (2015)

Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques
por: Al-Balas, Qosay A., et al.
Publicado: (2013)

Cytolytic toxin production by Staphylococcus aureus is dependent upon the activity of the protoheme IX farnesyltransferase
por: Stevens, Emily, et al.
Publicado: (2017)

Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice
por: Cuddy, Leah K., et al.
Publicado: (2022)

Antitumoral effect of farnesiltransferase and mtor inhibitors in hepatocellular carcinoma: in vitro studies
por: Araújo, Ana M, et al.
Publicado: (2010)

Defective Lamin A-Rb Signaling in Hutchinson-Gilford Progeria Syndrome and Reversal by Farnesyltransferase Inhibition
por: Marji, Jackleen, et al.
Publicado: (2010)

Rapid Analysis of Protein Farnesyltransferase Substrate Specificity Using Peptide Libraries and Isoprenoid Diphosphate Analogues
por: Wang, Yen-Chih, et al.
Publicado: (2014)

The Aspergillus fumigatus farnesyltransferase β-subunit, RamA, mediates growth, virulence, and antifungal susceptibility
por: Norton, Tiffany S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mhnivgq3mhti8jn4i9kgqc1qqb